株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

電気生理学 (EP) アブレーションカテーテル:医療機器のパイプライン評価

Electrophysiology Ablation Catheters - Medical Devices Pipeline Assessment, 2019

発行 GlobalData 商品コード 404488
出版日 ページ情報 英文 146 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.91円で換算しております。
Back to Top
電気生理学 (EP) アブレーションカテーテル:医療機器のパイプライン評価 Electrophysiology Ablation Catheters - Medical Devices Pipeline Assessment, 2019
出版日: 2019年12月20日 ページ情報: 英文 146 Pages
概要

当レポートでは、世界の電気生理学 (EP) アブレーションカテーテルの市場における、主要なパイプライン製品 (医療機器) とその治験の進行状況について調査すると共に、製品特性の比較分析 (治験の進行段階別) や、主要企業のプロファイルおよび代表的製品、昨今の市場動静 (資本取引・事業提携など) といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 イントロダクション

  • 前立腺がん診断検査の概要

第3章 現在治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:セグメント別
  • パイプライン製品:領域別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定認証時期別
  • 現在進行中の治験

第4章 EPアブレーションカテーテル:各企業で現在治験中のパイプライン製品

  • EPアブレーションカテーテルの企業:治験段階別のパイプライン製品
  • EPアブレーションカテーテル:治験段階別のパイプライン製品

第5章 EPアブレーションカテーテルの企業・製品の概要

  • Advanced Cardiac Therapeutics, Inc.
    • パイプライン製品および進行中の治験の概要
  • Apama Medical, Inc.
  • Biosense Webster Inc
  • BioTex Inc
  • Boston Scientific Corp
  • Cardima, Inc. (Inactive)
  • CardioNova Ltd.
  • CathEffects LLC
  • CathRx Ltd
  • Cordis Corp
  • CryoTherapeutics Gmbh
  • Epicardial Technologies Inc
  • FocusStart LLC
  • Interventional Imaging, Inc.
  • Iowa Approach Inc.
  • Maestro Heart SA
  • Mayo Clinic US
  • Medlumics S.L.
  • Medtronic plc
  • MedWaves Incorporated
  • MicroPort Scientific Corporation
  • North Carolina State University
  • Northwestern University
  • Ra Medical Systems Inc
  • SCR, Inc.
  • St. Jude Medical Inc
  • Stereotaxis Inc
  • Strategic Polymer Sciences, Inc
  • University of Iowa
  • University of Michigan
  • University of Rochester
  • University of Texas Medical Branch at Galveston
  • Vanderbilt University
  • Vimecon GmbH
  • Vivonics, Inc.
  • Voyage Medical (Inactive)

第6章 EPアブレーションカテーテル市場:昨今の動向 (全47件)

第7章 提言

図表一覧

図表

List of Tables

  • Table 1: Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development
  • Table 2: Electrophysiology Ablation Catheters - Pipeline Products by Segment
  • Table 3: Electrophysiology Ablation Catheters - Pipeline Products by Territory
  • Table 4: Electrophysiology Ablation Catheters - Pipeline Products by Regulatory Path
  • Table 5: Electrophysiology Ablation Catheters - Pipeline Products by Estimated Approval Date
  • Table 6: Electrophysiology Ablation Catheters - Ongoing Clinical Trials
  • Table 7: Electrophysiology Ablation Catheters Companies - Pipeline Products by Stage of Development
  • Table 8: Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development
  • Table 9: Ablacon Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Ablasense - Product Status
  • Table 11: Ablasense - Product Description
  • Table 12: Apama Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: LUMINIZE Radiofrequency (RF) Balloon Catheter - Product Status
  • Table 14: LUMINIZE Radiofrequency (RF) Balloon Catheter - Product Description
  • Table 15: Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: CARTO SMARTTOUCH 5D Catheter - Product Status
  • Table 17: CARTO SMARTTOUCH 5D Catheter - Product Description
  • Table 18: HELIOSTAR Multi-Electrode Radiofrequency Balloon Ablation Catheter - Product Status
  • Table 19: HELIOSTAR Multi-Electrode Radiofrequency Balloon Ablation Catheter - Product Description
  • Table 20: THERMOCOOL SMARTTOUCH SF-5D Catheter - Product Status
  • Table 21: THERMOCOOL SMARTTOUCH SF-5D Catheter - Product Description
  • Table 22: Biosense Webster Inc - Ongoing Clinical Trials Overview
  • Table 23: HELIOSTAR Multi-Electrode Radiofrequency Balloon Ablation Catheter - Safety and Effectiveness Evaluation of the Multi-electrode Radiofrequency Balloon Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation: STELLAR
  • Table 24: THERMOCOOL SMARTTOUCH SF-5D Catheter - U.S. Investigational Device Exemption (IDE) Study to Evaluate QDOT MICRO Radiofrequency (RF) Ablation Catheter for Treatment of Paroxysmal Atrial Fibrillation (AF)
  • Table 25: BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: Cooled Tip Catheter - Product Status
  • Table 27: Cooled Tip Catheter - Product Description
  • Table 28: Water-cooled Catheter - Product Status
  • Table 29: Water-cooled Catheter - Product Description
  • Table 30: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: Force Sensing Afib Catheter - Product Status
  • Table 32: Force Sensing Afib Catheter - Product Description
  • Table 33: Intellanav Stablepoint - Product Status
  • Table 34: Intellanav Stablepoint - Product Description
  • Table 35: Next Generation Blazer Catheter - Product Status
  • Table 36: Next Generation Blazer Catheter - Product Description
  • Table 37: Next Generation IntellaTip Catheter - Product Status
  • Table 38: Next Generation IntellaTip Catheter - Product Description
  • Table 39: POLARx Next Generation Catheter - Product Status
  • Table 40: POLARx Next Generation Catheter - Product Description
  • Table 41: POLARx Single Shot Cryoballoon - Product Status
  • Table 42: POLARx Single Shot Cryoballoon - Product Description
  • Table 43: Boston Scientific Corp - Ongoing Clinical Trials Overview
  • Table 44: POLARx Single Shot Cryoballoon - Safety and Effectiveness IDE Trial for Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation
  • Table 45: CardioNova Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 46: Electrophysiology Catheter - Atrial Fibrillation - Product Status
  • Table 47: Electrophysiology Catheter - Atrial Fibrillation - Product Description
  • Table 48: CathEffects LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: Desai VectorCathRF1 Mapping And Ablation Catheter - Product Status
  • Table 50: Desai VectorCathRF1 Mapping And Ablation Catheter - Product Description
  • Table 51: CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 52: CathRx 4mm Therapeutic Catheter - Product Status
  • Table 53: CathRx 4mm Therapeutic Catheter - Product Description
  • Table 54: CathRx 8mm Therapeutic Catheter - Product Status
  • Table 55: CathRx 8mm Therapeutic Catheter - Product Description
  • Table 56: Khelix Irrigated Ablation EP Catheter - Product Status
  • Table 57: Khelix Irrigated Ablation EP Catheter - Product Description
  • Table 58: Khelix Non-Irrigated Ablation EP Catheter - Product Status
  • Table 59: Khelix Non-Irrigated Ablation EP Catheter - Product Description
  • Table 60: Cibiem Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 61: Catheter-Based Carotid Body Ablation System - Product Status
  • Table 62: Catheter-Based Carotid Body Ablation System - Product Description
  • Table 63: Cibiem Inc - Ongoing Clinical Trials Overview
  • Table 64: Catheter-Based Carotid Body Ablation System - First-in-human Study for Ultrasound Based Endovascular Carotid Body Ablation in Subjects with Treatment-resistant Hypertension: A Safety and Feasibility Study

List of Figures

  • Figure 1: Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development
  • Figure 2: Electrophysiology Ablation Catheters - Pipeline Products by Segment
  • Figure 3: Electrophysiology Ablation Catheters - Pipeline Products by Territory
  • Figure 4: Electrophysiology Ablation Catheters - Pipeline Products by Regulatory Path
  • Figure 5: Electrophysiology Ablation Catheters - Pipeline Products by Estimated Approval Date
  • Figure 6: Electrophysiology Ablation Catheters - Ongoing Clinical Trials
目次
Product Code: GDME0883EPD

GlobalData's Medical Devices sector report, "Electrophysiology Ablation Catheters - Medical Devices Pipeline Assessment, 2019" provides an overview of Electrophysiology Ablation Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Electrophysiology Ablation Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Electrophysiology Ablation Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Electrophysiology Ablation Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Electrophysiology Ablation Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 6
  • 1.2 List of Figures 9

2 Introduction 10

  • 2.1 Electrophysiology Ablation Catheters Overview 10

3 Products under Development 11

  • 3.1 Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development 11
  • 3.2 Electrophysiology Ablation Catheters - Pipeline Products by Segment 12
  • 3.3 Electrophysiology Ablation Catheters - Pipeline Products by Territory 13
  • 3.4 Electrophysiology Ablation Catheters - Pipeline Products by Regulatory Path 14
  • 3.5 Electrophysiology Ablation Catheters - Pipeline Products by Estimated Approval Date 15
  • 3.6 Electrophysiology Ablation Catheters - Ongoing Clinical Trials 16

4 Electrophysiology Ablation Catheters - Pipeline Products under Development by Companies 17

  • 4.1 Electrophysiology Ablation Catheters Companies - Pipeline Products by Stage of Development 17
  • 4.2 Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development 19

5 Electrophysiology Ablation Catheters Companies and Product Overview 21

  • 5.1 Ablacon Inc Company Overview 21
    • 5.1.1 Ablacon Inc Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.2 Apama Medical Inc Company Overview 22
    • 5.2.1 Apama Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.3 Biosense Webster Inc Company Overview 23
    • 5.3.1 Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.4 BioTex Inc Company Overview 29
    • 5.4.1 BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.5 Boston Scientific Corp Company Overview 31
    • 5.5.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.6 CardioNova Ltd Company Overview 38
    • 5.6.1 CardioNova Ltd Pipeline Products & Ongoing Clinical Trials Overview 38
  • 5.7 CathEffects LLC Company Overview 39
    • 5.7.1 CathEffects LLC Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.8 CathRx Ltd Company Overview 40
    • 5.8.1 CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.9 Cibiem Inc Company Overview 43
    • 5.9.1 Cibiem Inc Pipeline Products & Ongoing Clinical Trials Overview 43
  • 5.10 Columbia University Company Overview 46
    • 5.10.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 46
  • 5.11 Cordis Corp Company Overview 47
    • 5.11.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.12 CoreMap Inc Company Overview 48
    • 5.12.1 CoreMap Inc Pipeline Products & Ongoing Clinical Trials Overview 48
  • 5.13 CryoTherapeutics Gmbh Company Overview 49
    • 5.13.1 CryoTherapeutics Gmbh Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.14 Epicardial Technologies Inc (Inactive) Company Overview 50
    • 5.14.1 Epicardial Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 50
  • 5.15 Eximo Medical Ltd Company Overview 51
    • 5.15.1 Eximo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 51
  • 5.16 Farapulse Inc Company Overview 52
    • 5.16.1 Farapulse Inc Pipeline Products & Ongoing Clinical Trials Overview 52
  • 5.17 FocusStart LLC Company Overview 56
    • 5.17.1 FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.18 Hyblate Medical Company Overview 57
    • 5.18.1 Hyblate Medical Pipeline Products & Ongoing Clinical Trials Overview 57
  • 5.19 Interventional Imaging, Inc. Company Overview 58
    • 5.19.1 Interventional Imaging, Inc. Pipeline Products & Ongoing Clinical Trials Overview 58
  • 5.20 Iowa Approach Inc. Company Overview 59
    • 5.20.1 Iowa Approach Inc. Pipeline Products & Ongoing Clinical Trials Overview 59

6 Electrophysiology Ablation Catheters- Recent Developments 90

  • 6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 90
  • 6.2 Nov 14, 2019: Stereotaxis reports 2019 third quarter financial results 92
  • 6.3 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 93
  • 6.4 Oct 31, 2019: CathVision Rrceives competitive EU Grant 94
  • 6.5 Oct 23, 2019: Boston Scientific announces results for third quarter 2019 94

7 Appendix 143

  • 7.1 Methodology 143
  • 7.2 About GlobalData 146
  • 7.3 Contact Us 146
  • 7.4 Disclaimer 146
Back to Top